These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21165400)

  • 21. Antiviral potential of exogenous human omega interferon to inhibit pandemic 2009 A (H1N1) influenza virus.
    Xu C; Song X; Fu L; Dong D; Wu S; Li G; Yi S; Yu T; Yu R; Hou L; Chen W
    Viral Immunol; 2011 Oct; 24(5):369-74. PubMed ID: 22004136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in Mice.
    Paukner S; Kimber S; Cumper C; Rea-Davies T; Sueiro Ballesteros L; Kirkham C; Hargreaves A; Gelone SP; Richards C; Wicha WW
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.
    Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus.
    Zhao J; Zhu M; Jiang H; Shen S; Su X; Shi Y
    Sci Rep; 2019 Mar; 9(1):5272. PubMed ID: 30918324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinations of L-N
    Smee DF; Dagley A; Tarbet EB
    Antivir Chem Chemother; 2017 Apr; 25(1):11-17. PubMed ID: 28417640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.
    Julander JG; Hagloch J; Latimer S; Motter N; Dagley A; Barnard DL; Smee DF; Morrey JD
    Antiviral Res; 2011 Nov; 92(2):228-36. PubMed ID: 21867731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
    Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ
    J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Clinacanthus siamensis leaf extract on influenza virus infection.
    Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C
    Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir.
    Koudstaal W; Koldijk MH; Brakenhoff JP; Cornelissen LA; Weverling GJ; Friesen RH; Goudsmit J
    J Infect Dis; 2009 Dec; 200(12):1870-3. PubMed ID: 19911992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of TheraMax on influenza virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH
    Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.
    Masihi KN; Schweiger B; Finsterbusch T; Hengel H
    J Chemother; 2007 Jun; 19(3):295-303. PubMed ID: 17594925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
    Jiang T; Zhao H; Li XF; Deng YQ; Liu J; Xu LJ; Han JF; Cao RY; Qin ED; Qin CF
    Antiviral Res; 2011 Jan; 89(1):124-6. PubMed ID: 21115063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).
    Zarogiannis SG; Noah JW; Jurkuvenaite A; Steele C; Matalon S; Noah DL
    Life Sci; 2012 Mar; 90(11-12):440-5. PubMed ID: 22269828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.
    Tanaka T; Kamiyama T; Daikoku T; Takahashi K; Nomura N; Kurokawa M; Shiraki K
    Acta Virol; 2017; 61(1):48-55. PubMed ID: 28105854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.
    Leyva-Grado VH; Palese P
    Antiviral Res; 2017 Jun; 142():12-15. PubMed ID: 28286235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.